We tested 5 major IBS treatments for 12 months. Which one is currently #1?

Bloating that won't quit. Cramping before every meal. Planning your entire day around bathroom access.

That's the reality for an estimated 1 in 10 people living with irritable bowel syndrome. And the #1 frustration patients report isn't the symptoms themselves. It's that nothing they try seems to work long-term.

So we looked at the 12-month clinical data on the five most common IBS treatments. Not the marketing claims. Not the 6-week snapshots. The actual sustained outcome data.

We tracked published trial results, patient-reported outcomes, and real-world adherence rates to answer one question: which IBS treatment actually delivers lasting relief?

Here's how they ranked.

#1: Gut-directed hypnotherapy

The only treatment that delivered lasting relief at 12 months with zero side effects

What it is: A structured clinical therapy where a trained practitioner uses guided relaxation and gut-specific imagery to retrain the communication loop between the gut and the brain. Based on the Manchester Protocol developed by Professor Peter Whorwell over four decades of research.

How it worked: This was the standout. Across multiple randomized controlled trials, gut-directed hypnotherapy consistently produced the highest response rates and the most durable outcomes of any treatment studied. In the University of Manchester trial of 354 patients, 70% achieved clinically meaningful improvement. At 12-month follow-up, the benefits had largely held. The standard-care group had regressed to baseline.

Functional MRI research by Dr. Olafur Palsson at the University of North Carolina shows it produces measurable changes in how the brain processes gut signals, effectively turning down the volume on visceral pain.

Data from clinical trials:

Symptom improvement: 70% of patients

Sustained at 12 months: Yes

Side effects: None reported

Patient recommendation rate: 82% (highest of any treatment surveyed)

Dropout rate: 11% (lowest of any treatment studied)

Pros

Largest effect size of any IBS treatment in systematic reviews

Directly addresses the gut-brain dysfunction that drives symptoms

Effects persist long after treatment ends

Zero side effects

Now accessible through digital programs for under $15/month

Cons

Requires daily engagement with a structured program (15 to 25 minutes)

In-person practitioners are scarce, though digital programs have closed this gap

Not yet widely recommended by GPs despite guideline endorsements

#2: Low-dose antidepressants (amitriptyline, SSRIs)

Effective for pain, but medication-dependent with meaningful side effects

What it is: Low-dose tricyclic antidepressants or SSRIs prescribed off-label to modulate gut-brain nerve signaling and reduce visceral pain sensitivity.

How it worked: The ATLANTIS trial, the largest RCT of low-dose amitriptyline for IBS, showed genuine benefit for pain-dominant symptoms. Patients reported less cramping and fewer flare-ups. However, the effects were entirely dependent on staying on the medication. Patients who discontinued typically saw symptoms return within weeks. And side effects were a persistent issue throughout the trial.

Data from clinical trials:

Symptom improvement: 55% of patients (NNT of 4.5)

Sustained at 12 months: Only while on medication

Side effects: Common (drowsiness, weight gain, dry mouth, sexual dysfunction, constipation)

Patient recommendation rate: 41%

Dropout rate: 38% (primarily due to side effects)

Pros

Strong evidence for pain-dominant IBS

Modulates gut-brain signaling, not just gut symptoms

Well-studied in large RCTs

Cons

Effects disappear when medication stops

Side effects are treatment-limiting for many patients

Weight gain and drowsiness reported frequently

Psychological barrier of taking an antidepressant for a gut condition

#3: Low-FODMAP diet

Good short-term diagnostic tool, but extremely hard to maintain

What it is: A structured elimination diet developed by Monash University that restricts fermentable carbohydrates found in foods like onions, garlic, wheat, dairy, and certain fruits.

How it worked: Initial results were encouraging. During the strict elimination phase, the majority of patients reported reduced bloating and fewer flare-ups. But the data changed dramatically at the 6-month mark. Most patients had drifted from the protocol. Social isolation, nutritional concerns, and the sheer difficulty of maintaining the diet long-term eroded the initial gains.

Data from clinical trials and adherence studies:

Symptom improvement: 52 to 76% during elimination phase

Sustained at 12 months: Approximately 34% still adherent

Side effects: Nutritional deficiency risk, reduced beneficial gut bacteria with prolonged restriction

Patient recommendation rate: 48%

Dropout rate: 44%

Pros

Effective for identifying personal food triggers

Strong short-term symptom relief during elimination phase

Well-researched and widely available

Cons

Extremely difficult to sustain beyond 6 months

Socially isolating (restaurants, friends' homes, travel)

Prolonged restriction can reduce beneficial Bifidobacteria in the gut

Does not address the underlying sensitivity that makes trigger foods problematic

Requires dietitian support, adding cost and access barriers

#4: Antispasmodics

Modest acute relief, but no long-term benefit

What it is: Medications like hyoscine butylbromide (Buscopan), mebeverine, and peppermint oil capsules that target smooth muscle spasms in the gut.

How it worked: Antispasmodics provided some relief for acute cramping episodes, particularly in patients with pain-dominant IBS. But the benefits were modest and inconsistent. They address one symptom (spasms) in a condition driven by multiple mechanisms. Most patients reported diminishing returns within a few months.

Data from clinical trials:

Symptom improvement: 20% meaningful benefit beyond placebo (NNT of 5)

Sustained at 12 months: No long-term benefit data

Side effects: Dry mouth, constipation, blurred vision, urinary retention

Patient recommendation rate: 29%

Dropout rate: 33%

Pros

Can help with acute cramping flare-ups

Widely available and inexpensive

Some formulations (peppermint oil) have minimal side effects

Cons

Modest effect at best

Does nothing to address the underlying gut-brain dysfunction

Effectiveness plateaus or diminishes over time

Side effects are common with prescription formulations

#5: Probiotics

Inconsistent evidence, mostly unregulated

What it is: Live bacterial supplements intended to improve gut microbiome composition. The market includes hundreds of commercial products with widely varying strain compositions.

How it worked: A handful of specific strains showed modest benefit for individual symptoms, particularly bloating. But the vast majority of commercial probiotic products have never been tested in IBS-specific clinical trials. Patients in studies and surveys consistently reported cycling through multiple products without finding consistent relief.

Data from clinical trials and reviews:

Symptom improvement: Variable (strain-dependent, overall evidence rated "low to very low certainty")

Sustained at 12 months: No consistent data

Side effects: Generally minimal

Patient recommendation rate: 22%

Dropout rate: 52% (patients stop when they see no results)

Average patient spend: $300 to $800 cycling through products

Pros

Generally safe with minimal side effects

A few specific strains (Bifidobacterium infantis 35624) have decent evidence for bloating

Widely available without prescription

Cons

Market is essentially unregulated

Most commercial products have no IBS-specific evidence

Patients spend significant money cycling through products that don't work

Overall evidence base rated "low to very low certainty" by systematic reviews

The bottom line

Every treatment on this list can provide some initial relief. But when you look at the 12-month data, the picture changes completely.

Most IBS treatments manage symptoms temporarily. Only one addresses the underlying gut-brain dysfunction that actually drives the condition. And it's the same one that showed the highest sustained response rate, the highest patient recommendation rate, the lowest dropout rate, and zero side effects.

The challenge for most patients is that they've never been assessed for what's actually causing their symptoms. If the primary driver is gut-brain miscommunication, then dietary changes, medications, and supplements are treating the wrong layer of the problem. Understanding whether that applies to you is the first step, and it's simpler than most people expect.